Joel Eisner Email & Phone Number | Dr. Eisner is Senior Vice President - Clinical & Corporate Development at GeneCentric Therapeutics. Previously he was a co-founder of Innocrin Pharmaceuticals and served as Vice President, Medical and Scientific Affairs and Vice President, Clinical Operations. He also served as a Director, Product Development of Viamet Pharmaceuticals, Principal of Cato BioVentures, Integrated Drug Development Scientist of Cato Research, and as Vice President, Corporate Development of Hemodynamic Therapeutics, and Durham Pharmaceuticals, each a portfolio company of Cato BioVentures. Dr. Eisner is an Affiliate Scientist at the National Primate Research Center, University of Wisconsin-Madison. Prior to joining CBV, Dr. Eisner was a Clinical Operations Manager at Northwestern University Medical School and Brigham and Women’s Hospital. Prior to that he served as a Clinical Research Scientist for Insmed, Inc. (NASDAQ: INSM). Dr. Eisner has 12 years’ research experience in the field of endocrinology and reproductive physiology, and his areas of expertise include obesity, reproductive endocrinology, lipid abnormalities, diabetes, women’s health, and infertility. He has over 20 years’ clinical research experience in both academic and pharmaceutical settings. Dr. Eisner is a member of the American Society of Clinical Oncology, The Endocrine Society and The Androgen Excess - PCOS Society. . Specialties: Active clinical and non-clinical research in the field of oncology (breast and prostate cancer), metabolism, reproductive endocrinology and obesity; experience in company formation and venture capital activities

Joel Eisner

Dr. Eisner is Senior Vice President - Clinical & Corporate Development at GeneCentric Therapeutics....
Durham, North Carolina, United States

*50 free lookup(s) per month.

No credit card required.

Joel Eisner’s Email joel.eisner@genecentric.com

Joel Eisner’s Phone Numbers

Get JOEL’s Phone Number (For Free)

Social Media

Joel Eisner’s Location Durham, North Carolina, United States

Joel Eisner’s Current Industry Boothe Mountain Advisors

Not the Joel Eisner you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Boothe Mountain Advisors

Principal Owner

2024-08-01T00:00:00.000Z - Present

Genecentric Therapeutics

Senior Vice President - Clinical and Corporate Development

2019-03-01T00:00:00.000Z - 2024-07-01T00:00:00.000Z

Innocrin Pharmaceuticals

Vice President Medical and Scientific Affairs

2016-09-01T00:00:00.000Z - 2019-03-01T00:00:00.000Z

Viamet Pharmaceuticals

Director, Product Development

2009-09-01T00:00:00.000Z - 2014-10-01T00:00:00.000Z

Hemodynamic Therapeutics

VP Corporate Development

2004-12-01T00:00:00.000Z - 2009-09-01T00:00:00.000Z

Cato Bioventures

Principal

2008-12-01T00:00:00.000Z - 2009-09-01T00:00:00.000Z

Durham Pharmaceuticals

VP Corporate Development

2004-12-01T00:00:00.000Z - 2007-09-01T00:00:00.000Z

Cato Bioventures Cato Research

Senior Associate

2002-04-01T00:00:00.000Z - 2007-01-01T00:00:00.000Z

Brigham And Womens Hospital Northwestern University Medical School

Clinical Scientist

2000-01-01T00:00:00.000Z - 2002-01-01T00:00:00.000Z

Insmed

Clinical Research Scientist

1999-01-01T00:00:00.000Z - 2000-01-01T00:00:00.000Z

Skills

No Skills Available

Languages

No Languages Available

FAQ About Joel Eisner

Joel Eisner is located at
Durham, North Carolina, United States

Joel Eisner is a Dr. Eisner is Senior Vice President - Clinical & Corporate Development at GeneCentric Therapeutics. Previously he was a co-founder of Innocrin Pharmaceuticals and served as Vice President, Medical and Scientific Affairs and Vice President, Clinical Operations. He also served as a Director, Product Development of Viamet Pharmaceuticals, Principal of Cato BioVentures, Integrated Drug Development Scientist of Cato Research, and as Vice President, Corporate Development of Hemodynamic Therapeutics, and Durham Pharmaceuticals, each a portfolio company of Cato BioVentures. Dr. Eisner is an Affiliate Scientist at the National Primate Research Center, University of Wisconsin-Madison. Prior to joining CBV, Dr. Eisner was a Clinical Operations Manager at Northwestern University Medical School and Brigham and Women’s Hospital. Prior to that he served as a Clinical Research Scientist for Insmed, Inc. (NASDAQ: INSM). Dr. Eisner has 12 years’ research experience in the field of endocrinology and reproductive physiology, and his areas of expertise include obesity, reproductive endocrinology, lipid abnormalities, diabetes, women’s health, and infertility. He has over 20 years’ clinical research experience in both academic and pharmaceutical settings. Dr. Eisner is a member of the American Society of Clinical Oncology, The Endocrine Society and The Androgen Excess - PCOS Society. . Specialties: Active clinical and non-clinical research in the field of oncology (breast and prostate cancer), metabolism, reproductive endocrinology and obesity; experience in company formation and venture capital activities

Joel Eisner currently works in the Boothe Mountain Advisors |

No Languages Available

Joel Eisner has prior
experience in the following industries:
Genecentric Therapeutics | Innocrin Pharmaceuticals | Viamet Pharmaceuticals | Hemodynamic Therapeutics | Cato Bioventures | Durham Pharmaceuticals | Cato Bioventures Cato Research | Brigham And Womens Hospital Northwestern University Medical School | Insmed

Joel Eisner has the following professional experience:
Boothe Mountain Advisors | Genecentric Therapeutics | Innocrin Pharmaceuticals | Viamet Pharmaceuticals | Hemodynamic Therapeutics | Cato Bioventures | Durham Pharmaceuticals | Cato Bioventures Cato Research | Brigham And Womens Hospital Northwestern University Medical School | Insmed